Keystone Symposia

This meeting took place in 2012

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Angiogenesis: Advances in Basic Science and Therapeutic Applications (A3)

Organizer(s) Napoleone Ferrara, Anne C. Eichmann and Kenneth Walsh
January 16—21, 2012
Snowbird Resort • Snowbird, UT USA
Abstract Deadline: Sep 19, 2011
Late Abstract Deadline: Oct 19, 2011
Scholarship Deadline: Sep 19, 2011
Early Registration Deadline: Nov 16, 2011

Sponsored by Bayer USA Foundation and Genentech, Inc.

Summary of Meeting:
Much progress has been made in the identification of key signaling pathways regulating blood vessel development. There is also evidence that various stromal cell types participate in normal and pathological angiogenesis in a tissue- or context-specific fashion. However, many important molecular and biological questions regarding these processes remain unanswered. In addition, several angiogenesis inhibitors have been approved by the FDA as therapy for cancer or intraocular neovascular disorders. Perhaps some of the most successful applications of anti-angiogenic therapy are in age-related macular degeneration and other intraocular neovascular diseases, although such findings have been rarely presented outside specialized meetings. The Keystone Symposia meeting on Angiogenesis: Advances in Basic Science and Therapeutic Applications will critically examine the latest basic science on the regulation of angiogenesis in health and disease, discuss the lessons from clinical trials in cancer and intraocular neovascular disorders and identify novel therapeutic targets. Additional discussion will focus on a renewed interest in therapeutic angiogenesis by tissue engineering or stem cell-based approaches.

View Meeting Program


National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Stacey D. Finley
University of Southern California, USA

National Heart, Lung, and Blood Institute (NHLBI) Scholarship Recipients

Gonçalo J. L. Bernardes
Institute of Pharmaceutical Sciences, Switzerland

Andrew John Brumm
University of California, Los Angeles, USA

Daniela Carnevale
IRCCS Neuromed, Italy

Zhonghua Liu
Carnegie Institution, USA

Iacovos Michael
Swiss Federal Institute of Technology Lausanne, Switzerland

Silvia Moimas
ICGEB, Italy

Sander W. Tas
Academic Medical Center, Netherlands

Bart Weijts
Utrecht University, Faculty of Veterinary Medicine, Netherlands

Florence T.H. Wu
Sunnybrook Research Institute, Canada